ARCUS VENTURES
Arcus Ventures is a private equity firm that invests in oncology-focused companies with advanced biopharmaceuticals. It also finances new drug delivery platforms in development, device companies with products that have pre-marketing approval, and service companies with positive revenue. Arcus Ventures was founded in 2007 by Steven L. Soignet, and James B. Dougherty. It is headquartered in New York, United States.
ARCUS VENTURES
Social Links:
Industry:
Biotechnology Finance Financial Services
Founded:
2007-01-01
Status:
Active
Contact:
212-785-2236
Email Addresses:
[email protected]
Technology used in webpage:
Amazon U.S. Server Location Amazon Ohio Region
Similar Organizations
Bluebird Ventures
Bluebird Ventures is an early-stage Life Sciences venture fund.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Vertex Ventures HC
Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-08-06 | Cleave Therapeutics | Arcus Ventures investment in Series C - Cleave Therapeutics | 12 M USD |
2017-07-24 | Exosome Diagnostics | Arcus Ventures investment in Series C - Exosome Diagnostics | 30 M USD |
2016-08-17 | Cleave Therapeutics | Arcus Ventures investment in Series B - Cleave Therapeutics | 37 M USD |
2016-01-07 | Exosome Diagnostics | Arcus Ventures investment in Series B - Exosome Diagnostics | 16 M USD |
2015-09-02 | Exosome Diagnostics | Arcus Ventures investment in Series B - Exosome Diagnostics | 17.6 M USD |
2015-06-11 | XTuit Pharmaceuticals | Arcus Ventures investment in Series A - XTuit Pharmaceuticals | 22 M USD |
2014-09-22 | TRACON Pharmaceuticals | Arcus Ventures investment in Series B - TRACON Pharmaceuticals | 27 M USD |
2014-07-30 | Epic Sciences | Arcus Ventures investment in Series C - Epic Sciences | 30 M USD |
2014-03-11 | Exosome Diagnostics | Arcus Ventures investment in Series B - Exosome Diagnostics | 27 M USD |
2013-10-02 | MI Bioresearch | Arcus Ventures investment in Series B - MI Bioresearch | 3.5 M USD |
More informations about "Arcus Ventures"
Arcus Ventures | Home
Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting and private โฆSee details»
Arcus Ventures - Crunchbase Investor Profile & Investments
Arcus Ventures is a private equity firm that invests in oncology-focused companies with advanced biopharmaceuticals. It also finances new drug delivery platforms in development, device โฆSee details»
Team - Arcus Ventures
Dr. Dougherty is a co-founder of Arcus Ventures. Before starting Arcus Ventures in 2007, Dr. Dougherty was the President of The Arcus Group, a consulting company that provided due โฆSee details»
Arcus Ventures investment portfolio | PitchBook
Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Arcus Ventures. Use the PitchBook Platform to explore the full profile.See details»
Arcus Ventures - Investments, Portfolio & Company Exits
Founded in 2007, Arcus Ventures invests in oncology-focused companies with advanced biopharmaceuticals and is a private equity company.See details»
Arcus Ventures - Funding, Financials, Valuation & Investors
Founded in 2007, Arcus Ventures invests in oncology-focused companies with advanced biopharmaceuticals and is a private equity company.See details»
Arcus Ventures - Private Equity List
Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting and private โฆSee details»
Team - Arcus Ventures
Dr. Soignet is a co-founder of Arcus Ventures. Before starting Arcus Ventures in 2007, Dr. Soignet was the Managing Director of The Arcus Group, a consulting company that provided due โฆSee details»
Arcus Ventures | Investments
A highly qualified management team is an essential success factor in any company. The management team must have the experience and leadership ability to execute exit strategies โฆSee details»
Arcus Ventures Raises $35.6M Toward 2nd Fund - PitchBook
Arcus Ventures, a New York-based VC firm, has raised $35.6 million towards its second fund, Arcus Ventures Fund II. The firm focuses its investments in oncology-oriented companies โฆSee details»
Arcus Ventures Fund: Performance - PitchBook
May 7, 2012ย ยท Arcus Ventures Fund is a venture capital fund managed by Arcus Ventures. The fund is located in New York, New York. The fund targeted healthcare devices, healthcare โฆSee details»
Arcus Ventures Fund Manager Profile | Preqin
Founded in 2007, Arcus Ventures is a US-based venture capital firm that seeks to raise funds in the early stages of commercialization. The firm specifically invests in therapeutics, diagnostics, โฆSee details»
Portfolio - Arcus Ventures
Private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. close. ยฉ 2018 ArcusVentures. Powered by โฆSee details»
Arcus Ventures โ 20 Investments, 5 Exits, 11 Portfolio companies ...
Arcus Ventures appeared to be the VC, which was created in 2007. The company was established in North America in United States. The main department of described VC is โฆSee details»
Arcus Ventures - Contacts, Employees, Board Members
Founded in 2007, Arcus Ventures invests in oncology-focused companies with advanced biopharmaceuticals and is a private equity company.See details»
ARCUS VENTURES LTD - Companies House
ARCUS VENTURES LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business โฆSee details»
James B. Dougherty - Co-Founder & General Partner @ Arcus โฆ
Before starting Arcus Ventures in 2007, Dr. Dougherty was the President of The Arcus Group, a consulting company that provided due diligence and strategic guidance for financial service โฆSee details»
Team - Arcus Ventures
Alex joined Arcus Ventures in September โ14. He is responsible for the day to day operations of the fund, including office management, bookkeeping, and supporting the General Partners. โฆSee details»
AHA Ventures News - American Heart Association
Apr 3, 2024ย ยท Read the latest on how AHA Ventures is amplifying the Associationโs mission to advance health and hope for everyone, everywhere by translating science and research to โฆSee details»
Contact - Arcus Ventures
Arcus Ventures 575 Fifth Avenue, Floor 14 New York, NY 10017 T. 212-785-2236 F. 212-785-2237 E-mail: [email protected] James B. Dougherty, MD, MBA General Partner โฆSee details»